Campaigners protest Palantir's NHS role at Labour conference as contract deadline looms

Groups urge government not to extend FDP contract worth up to £330 million

By LineZotpaper
Published
Read Time3 min
Health campaigners are protesting at the Labour Party conference in Liverpool as ministers consider whether to extend Palantir's contract to run the NHS Federated Data Platform, with critics citing concerns over vendor lock-in, data security, and the company's track record in surveillance and military technology.

MedAct and Just Treatment are coordinating protests at the ruling party's annual conference, with September 30 marking the contractual deadline for Palantir to provide NHS England with an exit plan should the government choose not to continue the arrangement. The contract's initial term ends early next year, after which the government can extend it for two years, followed by two further one-year extensions.

The Palantir-led Federated Data Platform (FDP) contract could be worth up to £330 million over seven years. Palantir won the lead role in November 2023 following a procurement process that NHS England maintains was open and fair. The award followed £60 million in COVID-era NHS contracts awarded without competition.

In June, the cross-party Science, Innovation and Technology Committee said Palantir should not play such a significant role in the UK public sector. It urged the government not to extend the FDP contract in 2027 and instead to develop an in-house replacement or seek a UK provider. "Vendor lock-in isn't inevitable, and the current position leaves us seriously exposed," committee chair Dame Chi Onwurah said.

Organizations opposing the rollout include the British Medical Association (BMA), public sector union UNISON, and the United Tech and Allied Workers Union. The BMA has urged members to consider avoiding the platform for purposes unrelated to direct care, citing risks to patient trust and data security. The Chief Data and Analytics Officers Network, which represents senior NHS data staff, has also urged the government to "consider the break clause." In a letter, it said the FDP "has been unable to demonstrate the level of evidence, confidence and realised value that should be expected following sustained investment and extensive policy support."

Dr Rhiannon Mihranian Osborne, a No Palantir in the NHS campaigner at MedAct, said: "Patients and NHS staff are united in their opposition to this contract, and the last three years have seen unprecedented levels of professional and patient campaigning. Over 85,000 patients have made formal complaints to their hospitals. The government has an urgent opportunity to choose patients and staff over big tech, it must take it."

Just Treatment spokesperson Hope Worsdale said: "Patients and health workers across England want Palantir out of our NHS. A company with a track record in surveillance, military technology and complicity in human rights abuses shouldn't be anywhere near our personal health data."

Palantir says its software is helping UK public bodies carry out more NHS operations, keep Royal Navy ships at sea for longer and tackle domestic violence. NHS England and Palantir say the platform links data held in disparate systems, helping hospitals use beds and operating theatres more efficiently and tackle the care backlog. Palantir maintains that the data processed through the FDP belongs to the NHS and that disclosing it to anyone else would breach its contract. Earlier this month, Palantir hired former Labour Party deputy Tom Watson to help guide its work with the UK government.

§

Analysis

Why This Matters

  • The decision on extending the FDP contract will affect how the NHS handles patient data and operational efficiency for years to come.
  • The outcome could set a precedent for public sector contracts with tech companies that have defense and surveillance links.
  • Patients and NHS staff are actively campaigning, with over 85,000 formal complaints already filed, indicating widespread concern.

Background

Palantir is a US data analytics company founded in 2003, known for its work with intelligence and military agencies. The Federated Data Platform is designed to link NHS data across different hospital systems to improve resource use, such as bed and operating theatre management. The contract was awarded after a competitive procurement, though earlier COVID-19 contracts worth £60 million were awarded without competition. Political opposition includes a cross-party parliamentary committee and several healthcare unions.

Key Perspectives

Palantir and NHS England: The FDP improves hospital efficiency and data integration, and all patient data remains owned by the NHS with strict contractual safeguards. Campaign groups (MedAct, Just Treatment): A company with a record in surveillance and military technology should not handle sensitive health data; the contract should end. NHS data staff and unions: Insufficient evidence of value; risks of vendor lock-in and compromised patient trust outweigh promised benefits.

What to Watch

  • Whether the government announces a decision on the contract extension before the initial term ends early next year.
  • The response from Palantir regarding the exit plan deadline and any new proposals from the company.
  • Further parliamentary scrutiny, especially if the FDP contract continues without demonstrated value.

Sources

Zotpaper

Written by software from the reporting listed above, scored by an automated standards desk, and published without a person reading it first. If something here is wrong, tell the editor and it will be put right.